Loading...

Saab Sammy

TitleProfessor
InstitutionUniversity of California Los Angeles
DepartmentMedicine
Address200 UCLA Medical Plaza #214
Los Angeles CA 90095
Phone(310) 206-6705
vCardDownload vCard
    Other Positions
    TitleProfessor

    TitleHead Outcomes Research in Hepatology

    TitleAssistant Professor


    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Saab S, Challita Y, Holloman D, Hathaway K, Kahaleh M, Nieto J. Case Series Review of the Safety and Efficacy of Endoscopic Ultrasound-Guided Splenic Mass Core Biopsy. Clin Endosc. 2018 Oct 04. PMID: 30286564.
      View in: PubMed
    2. Yanny B, Saab S, Durazo F, Latt N, Mitry A, Mikhail MM, Hanna RM, Aziz A, Sahota A. Eight-Week Hepatitis C Treatment with New Direct Acting Antivirals Has a Better Safety Profile While Being Effective in the Treatment-Naïve Geriatric Population Without Liver Cirrhosis and Hepatitis C Virus-RNA?
      View in: PubMed
    3. Aby ES, Lee E, Saggi SS, Viramontes MR, Grotts JF, Agopian VG, Busuttil RW, Saab S. Pretransplant Sarcopenia in Patients With NASH Cirrhosis Does Not Impact Rehospitalization or Mortality. J Clin Gastroenterol. 2018 Sep 01. PMID: 30180152.
      View in: PubMed
    4. Wu T, Morgan TR, Klein AS, Volk ML, Saab S, Sundaram V. Controversies in early liver transplantation for severe alcoholic hepatitis. Ann Hepatol. 2018 Aug 24; 17(5):759-768. PMID: 30145578.
      View in: PubMed
    5. Saab S, Kardashian A, Saggi S, Choi G, Agopian V, Tong MJ. Use of Hepatitis C Positive Grafts in Hepatitis C Negative Liver Transplant Recipients is Cost-Effective. Clin Transplant. 2018 Aug 21; e13383. PMID: 30129981.
      View in: PubMed
    6. Hanna RM, So N, Kaldas M, Hou J, Arman F, Sangalang M, Yanny B, Selamet U, Saab S, Nobakht N, Rastogi A. Case Report: Patient with Hepatitis C, p-ANCA, and Cryoglobulin Antibodies Presenting with Necrotizing Crescentic p-ANCA Glomerulonephritis. Case Rep Nephrol Dial. 2018 May-Aug; 8(2):161-170. PMID: 30197905.
      View in: PubMed
    7. Sikavi C, Najarian L, Saab S. Similar Sustained Virologic Response in Real-World and Clinical Trial Studies of Hepatitis C/Human Immunodeficiency Virus Coinfection. Dig Dis Sci. 2018 Aug 09. PMID: 30094623.
      View in: PubMed
    8. Saab S, Barnard A, Challita Y, Adeniyi A, Aziz A, Choi G, Durazo FA, El-Kabany MM, Han SB, Busuttil RW. Impact of Sustained Viral Response With Direct-Acting Agents on Glycemic Control and Renal Function in Hepatitis C Liver Transplant Recipients. Exp Clin Transplant. 2018 Aug; 16(4):419-424. PMID: 30060729.
      View in: PubMed
    9. Reardon LC, DePasquale EC, Tarabay J, Cruz D, Laks H, Biniwale RM, Busuttil RW, Kaldas FM, Saab S, Venick RS, Lin JP, Nsair A, Deng MC, Ardehali A, Caderias M, Iygengar A, Aboulhosn JA. Heart and heart-liver transplantation in adults with failing Fontan physiology. Clin Transplant. 2018 Jun 26; e13329. PMID: 29947122.
      View in: PubMed
    10. Aby E, Phan J, Truong E, Grotts J, Saab S. Inadequate Hepatocellular Carcinoma Screening in Patients With Nonalcoholic Steatohepatitis Cirrhosis. J Clin Gastroenterol. 2018 Jun 16. PMID: 29912761.
      View in: PubMed
    11. Phan J, Ng V, Sheinbaum A, French S, Choi G, El Kabany M, Durazo F, Saab S, Tong M, Busuttil R, Han SH. Hyperlipidemia and Nonalcoholic Steatohepatitis Predispose to Hepatocellular Carcinoma Development Without Cirrhosis. J Clin Gastroenterol. 2018 Jun 16. PMID: 29912756.
      View in: PubMed
    12. Lee EW, Saab S, Kaldas F, Fletcher S, Busuttil RW, Durazo F, McWilliams JP, DiNorcia J, Padia SA, Kee ST. Coil-Assisted Retrograde Transvenous Obliteration (CARTO): An Alternative Treatment Option for Refractory Hepatic Encephalopathy. Am J Gastroenterol. 2018 Jun 14. PMID: 29899437.
      View in: PubMed
    13. Chirikov VV, Marx SE, Manthena SR, Strezewski JP, Saab S. Development of a Comprehensive Dataset of Hepatitis C Patients and Examination of Disease Epidemiology in the United States, 2013-2016. Adv Ther. 2018 Jun 09. PMID: 29949038.
      View in: PubMed
    14. Saab S, Challita Y, Chen PH, Jimenez MA, Lee AD, Saab EG, Ahn T, Choi G, Durazo FA, El-Kabany MM, Han SB, Grotts J, Agopian VG, Busuttil RW. Elimination of Hepatitis C in Liver Transplant Recipients. J Clin Transl Hepatol. 2018 Sep 28; 6(3):247-250. PMID: 30271735.
      View in: PubMed
    15. Corson M, Moch A, Saab S. Hepatitis C Virus Treatment in Patients With Chronic Kidney Disease and in Kidney Transplant Recipients. Gastroenterol Hepatol (N Y). 2018 May; 14(5):280-285. PMID: 29991935.
      View in: PubMed
    16. Suraweera D, Fanous C, Jimenez M, Tong MJ, Saab S. Risk of Cardiovascular Events in Patients with Primary Biliary Cholangitis - Systematic Review. J Clin Transl Hepatol. 2018 Jun 28; 6(2):119-126. PMID: 29951355.
      View in: PubMed
    17. Sikavi C, Chen PH, Lee AD, Saab EG, Choi G, Saab S. Hepatitis C and human immunodeficiency virus coinfection in the era of direct-acting antiviral agents: No longer a difficult-to-treat population. Hepatology. 2018 Mar; 67(3):847-857. PMID: 29108121.
      View in: PubMed
    18. Yanny BT, Latt NL, Saab S, Han S, Choi G, Kramer J, Sahota AK. Risk of Hepatitis B Virus Reactivation Among Patients Treated With Ledipasvir-Sofosbuvir for Hepatitis C Virus Infection. J Clin Gastroenterol. 2018 Jan 12. PMID: 29334502.
      View in: PubMed
    19. Saab S, Mehta D, Hudgens S, Grunow N, Bao Y, Pinsky B. Effect of ombitasvir/paritaprevir/ritonavir + dasabuvir regimen on health-related quality of life for patients with hepatitis C. Liver Int. 2018 Jan 05. PMID: 29314597.
      View in: PubMed
    20. Saab S, Viramontes MR, Chalifoux SL, Craw CJ, Ramirez SD, Bau SN, Arevalo DG, Saab EG, Saab CE, Craw CS, Estafanous A, Messiah R, Messiah W, El Kabany M. Hepatitis C Virus Prevalence in Egyptian Americans in Southern California. J Clin Gastroenterol. 2018 Jan; 52(1):55-59. PMID: 28617761.
      View in: PubMed
    21. Saab S, Le L, Saggi S, Sundaram V, Tong M. Towards the Elimination of Hepatitis C in the United States. Hepatology. 2017 Nov 27. PMID: 29181853.
      View in: PubMed
    22. Chalifoux SL, Konyn PG, Choi G, Saab S. Extrahepatic Manifestations of Primary Biliary Cholangitis. Gut Liver. 2017 Nov 15; 11(6):771-780. PMID: 28292174.
      View in: PubMed
    23. Abaalkhail F, Elsiesy H, Elbeshbeshy H, Shawkat M, Yousif S, Ullah W, Alabbad S, Al-Jedai A, Ajlan A, Broering D, Saab S, Al Sebayel M, Al-Hamoudi W. Treatment of Patients With Hepatitis C Virus Infection With Ledipasvir-Sofosbuvir in the Liver Transplant Setting. Transplantation. 2017 11; 101(11):2739-2745. PMID: 28795982.
      View in: PubMed
    24. Saab S, Sikavi C, Jimenez M, Viramontes M, Allen R, Challita Y, Mai M, Esmailzadeh N, Grotts J, Choi G, Durazo F, El-Kabany M, Han SH, Moreno E. Clinical Food Addiction Is Not Associated with Development of Metabolic Complications in Liver Transplant Recipients. J Clin Transl Hepatol. 2017 Dec 28; 5(4):335-342. PMID: 29226100.
      View in: PubMed
    25. Suraweera D, Rahal H, Jimenez M, Viramontes M, Choi G, Saab S. Treatment of primary biliary cholangitis ursodeoxycholic acid non-responders: A systematic review. Liver Int. 2017 Dec; 37(12):1877-1886. PMID: 28517369.
      View in: PubMed
    26. Aby E, Jimenez MA, Grotts JF, Agopian V, French SW, Busuttil RW, Saab S. Diminishing Use of Liver Biopsy among Liver Transplant Recipients for Hepatitis C. J Clin Transl Hepatol. 2017 Sep 28; 5(3):197-202. PMID: 28936400.
      View in: PubMed
    27. Castrejón M, Chew KW, Javanbakht M, Humphries R, Saab S, Klausner JD. Implementation of a Large System-Wide Hepatitis C Virus Screening and Linkage to Care Program for Baby Boomers. Open Forum Infect Dis. 2017; 4(3):ofx109. PMID: 28752101.
      View in: PubMed
    28. Ahmed A, Gonzalez SA, Cholankeril G, Perumpail RB, McGinnis J, Saab S, Beckerman R, Younossi ZM. Treatment of patients waitlisted for liver transplant with all-oral direct-acting antivirals is a cost-effective treatment strategy in the United States. Hepatology. 2017 07; 66(1):46-56. PMID: 28257591.
      View in: PubMed
    29. Nieto J, Khaleel H, Challita Y, Jimenez M, Baron TH, Walters L, Hathaway K, Patel K, Lankarani A, Herman M, Holloman D, Saab S. EUS-guided fine-needle core liver biopsy sampling using a novel 19-gauge needle with modified 1-pass, 1 actuation wet suction technique. Gastrointest Endosc. 2018 02; 87(2):469-475. PMID: 28551024.
      View in: PubMed
    30. Saab S, Rheem J, Jimenez MA, Fong TM, Mai MH, Kachadoorian CA, Esmailzadeh NL, Bau SN, Kang S, Ramirez SD, Grotts J, Choi G, Durazo FA, El-Kabany MM, Han SB, Busuttil RW. Effectiveness of Ledipasvir/Sofosbuvir with/without Ribavarin in Liver Transplant Recipients with Hepatitis C. J Clin Transl Hepatol. 2017 Jun 28; 5(2):101-108. PMID: 28660147.
      View in: PubMed
    31. Tavakoli H, Robinson A, Liu B, Bhuket T, Younossi Z, Saab S, Ahmed A, Wong RJ. Cirrhosis Patients with Nonalcoholic Steatohepatitis Are Significantly Less Likely to Receive Surveillance for Hepatocellular Carcinoma. Dig Dis Sci. 2017 08; 62(8):2174-2181. PMID: 28474143.
      View in: PubMed
    32. Suraweera D, Saab S. Hepatitis C treatment threshold in patients with decompensated liver disease. Hepatology. 2017 06; 65(6):1789-1791. PMID: 28318048.
      View in: PubMed
    33. Suraweera D, Dutson E, Saab S. Liver Transplantation and Bariatric Surgery: Best Approach. Clin Liver Dis. 2017 May; 21(2):215-230. PMID: 28364810.
      View in: PubMed
    34. Wong RJ, Saab S, Ahmed A. Extrahepatic Manifestations of Hepatitis C Virus After Liver Transplantation. Clin Liver Dis. 2017 Aug; 21(3):595-606. PMID: 28689596.
      View in: PubMed
    35. Saab S, Phan J, Jimenez MA, Grotts JF, Walters L, Hathaway KA, Patel KR, Lankarani A, Herman M, Holloman DA, Nieto JM. Endoscopic Ultrasound Liver Biopsies Accurately Predict the Presence of Fibrosis in Patients With Fatty liver. Clin Gastroenterol Hepatol. 2017 Sep; 15(9):1477-1478. PMID: 28419859.
      View in: PubMed
    36. Stepanova M, Clement S, Wong R, Saab S, Ahmed A, Younossi ZM. Patients With Diabetes and Chronic Liver Disease Are at Increased Risk for Overall Mortality: A Population Study From the United States. Clin Diabetes. 2017 Apr; 35(2):79-83. PMID: 28442821.
      View in: PubMed
    37. Suraweera D, Jimenez M, Viramontes M, Jamal N, Grotts J, Elashoff D, Lee EW, Saab S. Age-related Morbidity and Mortality After Transjugular Intrahepatic Portosystemic Shunts. J Clin Gastroenterol. 2017 Apr; 51(4):360-363. PMID: 27159421.
      View in: PubMed
    38. Lin TY, Shekar AO, Li N, Yeh MW, Saab S, Wilson M, Leung AM. Incidence of abnormal liver biochemical tests in hyperthyroidism. Clin Endocrinol (Oxf). 2017 May; 86(5):755-759. PMID: 28199740.
      View in: PubMed
    39. Nguyen K, Jimenez M, Moghadam N, Wu C, Farid A, Grotts J, Elashoff D, Choi G, Durazo FA, El-Kabany MM, Han SB, Saab S. Decrease of Alpha-fetoprotein in Patients with Cirrhosis Treated with Direct-acting Antivirals. J Clin Transl Hepatol. 2017 Mar 28; 5(1):43-49. PMID: 28507926.
      View in: PubMed
    40. Suraweera D, Saab EG, Choi G, Saab S. Bariatric Surgery and Liver Transplantation. Gastroenterol Hepatol (N Y). 2017 Mar; 13(3):170-175. PMID: 28539844.
      View in: PubMed
    41. Patel AA, Walling AM, Ricks-Oddie J, May FP, Saab S, Wenger N. Palliative Care and Health Care Utilization for Patients With End-Stage Liver Disease at the End of Life. Clin Gastroenterol Hepatol. 2017 Oct; 15(10):1612-1619.e4. PMID: 28179192.
      View in: PubMed
    42. Younossi Z, Gordon SC, Ahmed A, Dieterich D, Saab S, Beckerman R. Treating Medicaid patients with hepatitis C: clinical and economic impact. Am J Manag Care. 2017 Feb; 23(2):107-112. PMID: 28245654.
      View in: PubMed
    43. Saab S, A Jimenez M, N Bau S, Choi G, Durazo FA, M El-Kabany M, Han SB, Busuttil RW. Use of Sofosbuvir-Based Treatment of Chronic Hepatitis C in Liver Transplant Recipients on Hemodialysis. J Clin Gastroenterol. 2017 Feb; 51(2):167-173. PMID: 27548734.
      View in: PubMed
    44. Saab S, Konyn PG, Viramontes MR, Jimenez MA, Grotts JF, Hamidzadah W, Dang VP, Esmailzadeh NL, Choi G, Durazo FA, El-Kabany MM, Han SB, Tong MJ. Limited Knowledge of Acetaminophen in Patients with Liver Disease. J Clin Transl Hepatol. 2016 Dec 28; 4(4):281-287. PMID: 28097095.
      View in: PubMed
    45. Younossi ZM, Park H, Dieterich D, Saab S, Ahmed A, Gordon SC. The value of cure associated with treating treatment-naïve chronic hepatitis C genotype 1: Are the new all-oral regimens good value to society? Liver Int. 2017 05; 37(5):662-668. PMID: 27804195.
      View in: PubMed
    46. May FP, Rolston VS, Tapper EB, Lakshmanan A, Saab S, Sundaram V. The impact of race and ethnicity on mortality and healthcare utilization in alcoholic hepatitis: a cross-sectional study. BMC Gastroenterol. 2016 Oct 10; 16(1):129. PMID: 27724882.
      View in: PubMed
    47. Young K, Aguilar M, Gish R, Younossi Z, Saab S, Bhuket T, Liu B, Ahmed A, Wong RJ. Lower rates of receiving model for end-stage liver disease exception and longer time to transplant among nonalcoholic steatohepatitis hepatocellular carcinoma. Liver Transpl. 2016 10; 22(10):1356-66. PMID: 27348270.
      View in: PubMed
    48. Barnard A, Konyn P, Saab S. Medical Management of Metabolic Complications of Liver Transplant Recipients. Gastroenterol Hepatol (N Y). 2016 Oct; 12(10):601-608. PMID: 27917074.
      View in: PubMed
    49. Younossi ZM, Park H, Dieterich D, Saab S, Ahmed A, Gordon SC. Assessment of cost of innovation versus the value of health gains associated with treatment of chronic hepatitis C in the United States: The quality-adjusted cost of care. Medicine (Baltimore). 2016 Oct; 95(41):e5048. PMID: 27741116.
      View in: PubMed
    50. Saab S, Chen PY, Saab CE, Tong MJ. The Management of Hepatitis B in Liver Transplant Recipients. Clin Liver Dis. 2016 Nov; 20(4):721-736. PMID: 27742010.
      View in: PubMed
    51. Suraweera D, Sundaram V, Saab S. Evaluation and Management of Hepatic Encephalopathy: Current Status and Future Directions. Gut Liver. 2016 Jul 15; 10(4):509-19. PMID: 27377741; PMCID: PMC4933409.
    52. Lee EW, Kuei A, Saab S, Busuttil RW, Durazo F, Han SH, El-Kabany MM, McWilliams JP, Kee ST. Nationwide trends and predictors of inpatient mortality in 83884 transjugular intrahepatic portosystemic shunt. World J Gastroenterol. 2016 Jul 07; 22(25):5780-9. PMID: 27433091; PMCID: PMC4932213.
    53. Suraweera D, Weeratunga AN, Saab S. Spotlight on grazoprevir-elbasvir once-daily combination and its potential in the treatment of hepatitis C. Drug Des Devel Ther. 2016; 10:2119-27. PMID: 27418810; PMCID: PMC4933565.
    54. Kuei A, Lee EW, Saab S, Busuttil RW, Durazo F, Han SH, ElKabany M, McWilliams JP, Kee ST. Inpatient Cost Assessment of Transjugular Intrahepatic Portosystemic Shunt in the USA from 2001 to 2012. Dig Dis Sci. 2016 10; 61(10):2838-2846. PMID: 27349987.
      View in: PubMed
    55. Lee EW, Alanis L, Cho SK, Saab S. Yttrium-90 Selective Internal Radiation Therapy with Glass Microspheres for Hepatocellular Carcinoma: Current and Updated Literature Review. Korean J Radiol. 2016 Jul-Aug; 17(4):472-88. PMID: 27390539; PMCID: PMC4936170.
    56. Saab S, Virabhak S, Parisé H, Johnson S, Wang A, Misurski D, Gonzalez YS, Juday T. Cost-Effectiveness of Genotype 1 Chronic Hepatitis C Virus Treatments in Patients Coinfected with Human Immunodeficiency Virus in the United States. Adv Ther. 2016 Aug; 33(8):1316-30. PMID: 27342742.
      View in: PubMed
    57. Saab S, Jimenez M, Fong T, Wu C, Bau S, Jamal Z, Grotts J, Elashoff D. Accessibility to Oral Antiviral Therapy for Patients with Chronic Hepatitis C in the United States. J Clin Transl Hepatol. 2016 Jun 28; 4(2):76-82. PMID: 27350937; PMCID: PMC4913077.
    58. Suraweera D, Saab EG, Tong MJ, Saab S. Timing of Hepatitis C Antiviral Therapy in Liver Transplant Recipients With Direct-acting Agents. Exp Clin Transplant. 2016 06; 14(3):243-51. PMID: 27221717.
      View in: PubMed
    59. Molski C, Mattiello R, Sarria EE, Saab S, Medeiros R, Brandão A.  Cultural validation of the post-Liver transplant quality of life (pLTQ) questionnaire for the Brazilian population. Ann Hepatol. 2016 May-Jun; 15(3):377-85. PMID: 27049491.
      View in: PubMed
    60. Younossi ZM, Park H, Gordon SC, Ferguson JR, Ahmed A, Dieterich D, Saab S. Real-world outcomes of ledipasvir/sofosbuvir in treatment-naive patients with hepatitis C. Am J Manag Care. 2016 May; 22(6 Spec No.):SP205-11. PMID: 27266950.
      View in: PubMed
    61. Saab S, Parisé H, Virabhak S, Wang A, Marx SE, Sanchez Gonzalez Y, Misurski D, Johnson S. Cost-effectiveness of currently recommended direct-acting antiviral treatments in patients infected with genotypes 1 or 4 hepatitis C virus in the US. J Med Econ. 2016 Aug; 19(8):795-805. PMID: 27063573.
      View in: PubMed
    62. Saab S, Rheem J, Jimenez M, Bau S, Choi G, Durazo F, El Kabany M, Han S, Farid A, Jamal N, Grotts J, Elashoff D, Busuttil RW. Curing Hepatitis C in Liver Transplant Recipients Is Associated with Changes in Immunosuppressant Use. J Clin Transl Hepatol. 2016 Mar 28; 4(1):32-8. PMID: 27047770; PMCID: PMC4807141.
    63. Sheen V, Nguyen H, Jimenez M, Agopian V, Vangala S, Elashoff D, Saab S. Routine Laboratory Blood Tests May Diagnose Significant Fibrosis in Liver Transplant Recipients with Chronic Hepatitis C: A 10 Year Experience. J Clin Transl Hepatol. 2016 Mar 28; 4(1):20-5. PMID: 27047768; PMCID: PMC4807139.
    64. Suraweera D, Saab EG, Tong MJ, Saab S. Timing of Hepatitis C Antiviral Therapy in Liver Transplant Recipients With Direct-acting Agents. Exp Clin Transplant. 2016 02 26. PMID: 26925931.
      View in: PubMed
    65. Saab S, Park SH, Mizokami M, Omata M, Mangia A, Eggleton E, Zhu Y, Knox SJ, Pang P, Subramanian M, Kowdley K, Afdhal NH. Safety and efficacy of ledipasvir/sofosbuvir for the treatment of genotype 1 hepatitis C in subjects aged 65 years or older. Hepatology. 2016 Apr; 63(4):1112-9. PMID: 26704693.
      View in: PubMed
    66. Suraweera D, Sundaram V, Saab S. Treatment of Hepatitis C Virus Infection in Liver Transplant Recipients. Gastroenterol Hepatol (N Y). 2016 Jan; 12(1):23-30. PMID: 27330501; PMCID: PMC4865783.
    67. Saab S, Gonzalez YS, Huber C, Wang A, Juday T. Cost-effectiveness of Ombitasvir/Paritaprevir/Ritonavir, Dasabuvir+Ribavirin for US Post-Liver Transplant Recurrent Genotype 1 HCV. Liver Int. 2016 Apr; 36(4):515-21. PMID: 26610059.
      View in: PubMed
    68. Saab S, Suraweera D, Au J, Saab EG, Alper TS, Tong MJ. Probiotics are helpful in hepatic encephalopathy: a meta-analysis of randomized trials. Liver Int. 2016 07; 36(7):986-93. PMID: 26561214.
      View in: PubMed
    69. Saab S, Zhou K, Chang EK, Busuttil RW. De novo Hepatocellular Carcinoma after Liver Transplantation. J Clin Transl Hepatol. 2015 Dec 28; 3(4):284-7. PMID: 26807385; PMCID: PMC4721897.
    70. Stepanova M, Henry L, Garg R, Kalwaney S, Saab S, Younossi Z. Risk of de novo post-transplant type 2 diabetes in patients undergoing liver transplant for non-alcoholic steatohepatitis. BMC Gastroenterol. 2015 Dec 15; 15:175. PMID: 26666336.
      View in: PubMed
    71. Cheng EY, Saab S, Holt CD, Busuttil RW. Paritaprevir/ritonavir/ombitasvir and dasabuvir for the treatment of chronic hepatitis C virus infection. Expert Opin Pharmacother. 2015; 16(18):2835-48. PMID: 26646975.
      View in: PubMed
    72. Lu NT, Crespi CM, Liu NM, Vu JQ, Ahmadieh Y, Wu S, Lin S, McClune A, Durazo F, Saab S, Han S, Neiman DC, Beaven S, French SW. A Phase I Dose Escalation Study Demonstrates Quercetin Safety and Explores Potential for Bioflavonoid Antivirals in Patients with Chronic Hepatitis C. Phytother Res. 2016 Jan; 30(1):160-8. PMID: 26621580.
      View in: PubMed
    73. Saab S, Jimenez M, Fong T, Wu C, El Kabany M, Tong MJ. Timing of Antiviral Therapy in Candidates for Liver Transplant for Hepatitis C and Hepatocellular Carcinoma. Exp Clin Transplant. 2016 Feb; 14(1):66-71. PMID: 26581477.
      View in: PubMed
    74. Perumpail RB, Wong RJ, Scandling JD, Ha le D, Todo T, Bonham CA, Saab S, Younossi ZM, Ahmed A. HCV infection is associated with lower survival in simultaneous liver kidney transplant recipients in the United States. Clin Transplant. 2015 Oct; 29(10):920-6. PMID: 26205329.
      View in: PubMed
    75. Saab S, Jimenez M, Bau S, Goo T, Zhao D, Durazo F, Han S, El Kabany M, Kaldas F, Tong MJ, Busuttil RW. Treating fibrosing cholestatic hepatitis C with sofosbuvir and ribavirin: a matched analysis. Clin Transplant. 2015 Sep; 29(9):813-9. PMID: 26147216.
      View in: PubMed
    76. Kuei A, Saab S, Cho SK, Kee ST, Lee EW. Effects of Yttrium-90 selective internal radiation therapy on non-conventional liver tumors. World J Gastroenterol. 2015 Jul 21; 21(27):8271-83. PMID: 26217079; PMCID: PMC4507097.
    77. Al-Hamoudi W, Elsiesy H, Bendahmash A, Al-Masri N, Ali S, Allam N, Al Sofayan M, Al Bahili H, Al Sebayel M, Broering D, Saab S, Abaalkhail F. Liver transplantation for hepatitis B virus: Decreasing indication and changing trends. World J Gastroenterol. 2015 Jul 14; 21(26):8140-7. PMID: 26185387; PMCID: PMC4499358.
    78. Saab S, Rheem J, Sundaram V. Hepatitis C Infection in the Elderly. Dig Dis Sci. 2015 Nov; 60(11):3170-80. PMID: 26008618.
      View in: PubMed
    79. Saab S, Alper T, Sernas E, Pruthi P, Alper MA, Sundaram V. Hospitalized Patients with Cirrhosis Should Be Screened for Clostridium difficile Colitis. Dig Dis Sci. 2015 Oct; 60(10):3124-9. PMID: 25986524.
      View in: PubMed
    80. Saab S, Greenberg A, Li E, Bau SN, Durazo F, El-Kabany M, Han S, Busuttil RW. Sofosbuvir and simeprevir is effective for recurrent hepatitis C in liver transplant recipients. Liver Int. 2015 Nov; 35(11):2442-7. PMID: 25913321.
      View in: PubMed
    81. Saab S, Manne V, Nieto J, Schwimmer JB, Chalasani NP. Nonalcoholic Fatty Liver Disease in Latinos. Clin Gastroenterol Hepatol. 2016 Jan; 14(1):5-12; quiz e9-10. PMID: 25976180.
      View in: PubMed
    82. Saab S. Evaluation of the impact of rehospitalization in the management of hepatic encephalopathy. Int J Gen Med. 2015; 8:165-73. PMID: 25999756; PMCID: PMC4427083.
    83. Rheem J, Sundaram V, Saab S. Antiviral Therapy in Elderly Patients With Hepatitis C Virus Infection. Gastroenterol Hepatol (N Y). 2015 May; 11(5):294-346. PMID: 27482173; PMCID: PMC4962680.
    84. Choi G, Lee KG, Wu C, Saab S. Kidney transplantation threshold in patients with hepatitis C: a decision analysis model. Transplantation. 2015 Apr; 99(4):829-34. PMID: 25222014.
      View in: PubMed
    85. Quirk M, Kim YH, Saab S, Lee EW. Management of hepatocellular carcinoma with portal vein thrombosis. World J Gastroenterol. 2015 Mar 28; 21(12):3462-71. PMID: 25834310; PMCID: PMC4375567.
    86. Stepanova M, Wai H, Saab S, Mishra A, Venkatesan C, Younossi ZM. The outcomes of adult liver transplants in the United States from 1987 to 2013. Liver Int. 2015 Aug; 35(8):2036-41. PMID: 25559873.
      View in: PubMed
    87. Modi R, Saab S. Hepatitis C Virus Infection Is Systemic: Meeting Additional Goals. J Infect Dis. 2015 Aug 01; 212(3):343-4. PMID: 25583165.
      View in: PubMed
    88. Park JK, Saab S, Kee ST, Busuttil RW, Kim HJ, Durazo F, Cho SK, Lee EW. Balloon-Occluded Retrograde Transvenous Obliteration (BRTO) for Treatment of Gastric Varices: Review and Meta-Analysis. Dig Dis Sci. 2015 Jun; 60(6):1543-53. PMID: 25519690.
      View in: PubMed
    89. Saab S. Surveillance for Hepatocellular Carcinoma. Gastroenterol Hepatol (N Y). 2014 Nov; 10(11):745-747. PMID: 28435411.
      View in: PubMed
    90. Lee EW, Saab S, Gomes AS, Busuttil R, McWilliams J, Durazo F, Han SH, Goldstein L, Tafti BA, Moriarty J, Loh CT, Kee ST. Coil-Assisted Retrograde Transvenous Obliteration (CARTO) for the Treatment of Portal Hypertensive Variceal Bleeding: Preliminary Results. Clin Transl Gastroenterol. 2014 Oct 02; 5:e61. PMID: 25273155; PMCID: PMC4218931.
    91. Manne V, Akhtar E, Saab S. Cirrhosis regression in patients with viral hepatitis B and C: a systematic review. J Clin Gastroenterol. 2014 Oct; 48(9):e76-84. PMID: 24921210.
      View in: PubMed
    92. Saab S, Younossi ZM. Editorial: can we afford the new direct-acting anti-virals for treatment of genotype 1 hepatitis C? Authors' reply. Aliment Pharmacol Ther. 2014 Oct; 40(8):984-5. PMID: 25229814.
      View in: PubMed
    93. Curry MP, Forns X, Chung RT, Terrault NA, Brown R, Fenkel JM, Gordon F, O'Leary J, Kuo A, Schiano T, Everson G, Schiff E, Befeler A, Gane E, Saab S, McHutchison JG, Subramanian GM, Symonds WT, Denning J, McNair L, Arterburn S, Svarovskaia E, Moonka D, Afdhal N. Sofosbuvir and ribavirin prevent recurrence of HCV infection after liver transplantation: an open-label study. Gastroenterology. 2015 Jan; 148(1):100-107.e1. PMID: 25261839.
      View in: PubMed
    94. Saab S, Jackson C, Nieto J, Francois F. Hepatitis C in African Americans. Am J Gastroenterol. 2014 Oct; 109(10):1576-84; quiz 1575, 1585. PMID: 25178700.
      View in: PubMed
    95. Stepanova M, Wai H, Saab S, Mishra A, Venkatesan C, Younossi ZM. The portrait of an adult liver transplant recipient in the United States from 1987 to 2013. JAMA Intern Med. 2014 Aug; 174(8):1407-9. PMID: 24978860.
      View in: PubMed
    96. Manne V, Sassi K, Allen R, Saab S. Hepatitis C and work impairment: a review of current literature. J Clin Gastroenterol. 2014 Aug; 48(7):595-9. PMID: 24492408.
      View in: PubMed
    97. Zhou K, Ferguson J, Bau S, Saab S. Viral breakthrough is associated with resistance using direct acting agents in patients treated for chronic hepatitis C infection. J Clin Gastroenterol. 2014 Jul; 48(6):548-52. PMID: 24045279.
      View in: PubMed
    98. Akhtar E, Manne V, Saab S. Cirrhosis regression in hepatitis C patients with sustained virological response after antiviral therapy: a meta-analysis. Liver Int. 2015 Jan; 35(1):30-6. PMID: 24766091.
      View in: PubMed
    99. Klintmalm GB, Saab S, Hong JC, Nashan B. The role of mammalian target of rapamycin inhibitors in the management of post-transplant malignancy. Clin Transplant. 2014 Jun; 28(6):635-48. PMID: 24628264.
      View in: PubMed
    100. Saab S, Manne V, Bau S, Reynolds JA, Allen R, Goldstein L, Durazo F, El-Kabany M, Han S, Busuttil RW. Boceprevir in liver transplant recipients. Liver Int. 2015 Jan; 35(1):192-7. PMID: 24673728.
      View in: PubMed
    101. Sundaram V, May FP, Manne V, Saab S. Effects of Clostridium difficile infection in patients with alcoholic hepatitis. Clin Gastroenterol Hepatol. 2014 Oct; 12(10):1745-52.e2. PMID: 24681081; PMCID: PMC4171202.
    102. Terrault NA, Stravitz RT, Lok AS, Everson GT, Brown RS, Kulik LM, Olthoff KM, Saab S, Adeyi O, Argo CK, Everhart JE, Rodrigo del R. Hepatitis C disease severity in living versus deceased donor liver transplant recipients: an extended observation study. Hepatology. 2014 Apr; 59(4):1311-9. PMID: 24677192; PMCID: PMC4118586.
    103. Manne V, Allen RM, Saab S. Strategies for the prevention of recurrent hepatitis B virus infection after liver transplantation. Gastroenterol Hepatol (N Y). 2014 Mar; 10(3):175-9. PMID: 24829544; PMCID: PMC4014049.
    104. McCombs J, Matsuda T, Tonnu-Mihara I, Saab S, Hines P, L'italien G, Juday T, Yuan Y. The risk of long-term morbidity and mortality in patients with chronic hepatitis C: results from an analysis of data from a Department of Veterans Affairs Clinical Registry. JAMA Intern Med. 2014 Feb 01; 174(2):204-12. PMID: 24193887.
      View in: PubMed
    105. Sood A, Castrejón M, Saab S. Human immunodeficiency virus and nodular regenerative hyperplasia of liver: A systematic review. World J Hepatol. 2014 Jan 27; 6(1):55-63. PMID: 24653794; PMCID: PMC3953810.
    106. Wai H, Stepanova M, Saab S, Erario M, Srishord M, Younossi ZM. Inpatient economic and mortality assessment for liver transplantation: a nationwide study of the United States data from 2005 to 2009. Transplantation. 2014 Jan 15; 97(1):98-103. PMID: 24056627.
      View in: PubMed
    107. Saab S, Lalezari D, Pruthi P, Alper T, Tong MJ. The impact of obesity on patient survival in liver transplant recipients: a meta-analysis. Liver Int. 2015 Jan; 35(1):164-70. PMID: 24313970.
      View in: PubMed
    108. Manne V, Saab S. Impact of nutrition and obesity on chronic liver disease. Clin Liver Dis. 2014 Feb; 18(1):205-18. PMID: 24274875.
      View in: PubMed
    109. Saab S, Mallam D, Cox GA, Tong MJ. Impact of coffee on liver diseases: a systematic review. Liver Int. 2014 Apr; 34(4):495-504. PMID: 24102757.
      View in: PubMed
    110. Campsen J, Zimmerman M, Trotter J, Hong J, Freise C, Brown RS, Cameron A, Ghobrial M, Kam I, Busuttil R, Saab S, Holt C, Emond JC, Stiles JB, Lukose T, Chang MS, Klintmalm G. Multicenter review of liver transplant for hepatitis B-related liver disease: disparities in gender and ethnicity. Clin Transplant. 2013 Nov-Dec; 27(6):829-37. PMID: 24033475.
      View in: PubMed
    111. Agopian VG, Petrowsky H, Kaldas FM, Zarrinpar A, Farmer DG, Yersiz H, Holt C, Harlander-Locke M, Hong JC, Rana AR, Venick R, McDiarmid SV, Goldstein LI, Durazo F, Saab S, Han S, Xia V, Hiatt JR, Busuttil RW. The evolution of liver transplantation during 3 decades: analysis of 5347 consecutive liver transplants at a single center. Ann Surg. 2013 Sep; 258(3):409-21. PMID: 24022434.
      View in: PubMed
    112. Campsen J, Zimmerman M, Trotter J, Hong J, Freise C, Brown R, Cameron A, Ghobrial M, Kam I, Busuttil R, Saab S, Holt C, Emond J, Stiles J, Lukose T, Chang M, Klintmalm G. Liver transplantation for hepatitis B liver disease and concomitant hepatocellular carcinoma in the United States With hepatitis B immunoglobulin and nucleoside/nucleotide analogues. Liver Transpl. 2013 Sep; 19(9):1020-9. PMID: 23852663.
      View in: PubMed
    113. Ng V, Saab S. Can daily coffee consumption reduce liver disease-related mortality? Clin Gastroenterol Hepatol. 2013 Nov; 11(11):1422-3. PMID: 23811247.
      View in: PubMed
    114. Sood A, Cox GA, McWilliams JP, Wang HL, Saab S. Patients with nodular regenerative hyperplasia should be considered for hepatocellular carcinoma screening. Hepatol Res. 2014 Jun; 44(6):689-93. PMID: 23607291.
      View in: PubMed
    115. Yu C, Sharma N, Saab S. Hyponatremia: clinical associations, prognosis, and treatment in cirrhosis. Exp Clin Transplant. 2013 Feb; 11(1):3-11. PMID: 23387536.
      View in: PubMed
    116. Everson GT, Terrault NA, Lok AS, Rodrigo del R, Brown RS, Saab S, Shiffman ML, Al-Osaimi AM, Kulik LM, Gillespie BW, Everhart JE. A randomized controlled trial of pretransplant antiviral therapy to prevent recurrence of hepatitis C after liver transplantation. Hepatology. 2013 May; 57(5):1752-62. PMID: 22821361; PMCID: PMC3510348.
    117. Rubin J, Ayoub N, Kaldas F, Saab S. Management of recurrent hepatocellular carcinoma in liver transplant recipients: a systematic review. Exp Clin Transplant. 2012 Dec; 10(6):531-43. PMID: 23216564.
      View in: PubMed
    118. Saab S, Choi Y, Rahal H, Li K, Tong M. Trends in viral hepatitis cost-effectiveness studies. Am J Manag Care. 2012 Dec; 18(12):790-8. PMID: 23286609.
      View in: PubMed
    119. Chavalitdhamrong D, Jensen DM, Singh B, Kovacs TO, Han SH, Durazo F, Saab S, Gornbein JA. Capsule endoscopy is not as accurate as esophagogastroduodenoscopy in screening cirrhotic patients for varices. Clin Gastroenterol Hepatol. 2012 Mar; 10(3):254-8.e1. PMID: 22155754.
      View in: PubMed
    120. McCombs JS, Yuan Y, Shin J, Saab S. Economic burden associated with patients diagnosed with hepatitis C. Clin Ther. 2011 Sep; 33(9):1268-80. PMID: 21840056.
      View in: PubMed
    121. Ng V, Saab S. Effects of a sustained virologic response on outcomes of patients with chronic hepatitis C. Clin Gastroenterol Hepatol. 2011 Nov; 9(11):923-30. PMID: 21699815.
      View in: PubMed
    122. Hong JC, Jones CM, Duffy JP, Petrowsky H, Farmer DG, French S, Finn R, Durazo FA, Saab S, Tong MJ, Hiatt JR, Busuttil RW. Comparative analysis of resection and liver transplantation for intrahepatic and hilar cholangiocarcinoma: a 24-year experience in a single center. Arch Surg. 2011 Jun; 146(6):683-9. PMID: 21690444.
      View in: PubMed
    123. Khungar V, Saab S. Cirrhosis with refractory ascites: serial large volume paracentesis, TIPS, or transplantation? Clin Gastroenterol Hepatol. 2011 Nov; 9(11):931-5; quiz e121-2. PMID: 21627999.
      View in: PubMed
    124. Saab S, Bownik H, Ayoub N, Younossi Z, Durazo F, Han S, Hong JC, Farmer D, Busuttil RW. Differences in health-related quality of life scores after orthotopic liver transplantation with respect to selected socioeconomic factors. Liver Transpl. 2011 May; 17(5):580-90. PMID: 21506246.
      View in: PubMed
    125. Saab S, Ng V, Landaverde C, Lee SJ, Comulada WS, Arevalo J, Durazo F, Han SH, Younossi Z, Busuttil RW. Development of a disease-specific questionnaire to measure health-related quality of life in liver transplant recipients. Liver Transpl. 2011 May; 17(5):567-79. PMID: 21506245.
      View in: PubMed
    126. Hong JC, Petrowsky H, Kaldas FM, Farmer DG, Durazo FA, Finn RS, Saab S, Han SH, Lee P, Markovic D, Lassman C, Hiatt JR, Busuttil RW. Predictive index for tumor recurrence after liver transplantation for locally advanced intrahepatic and hilar cholangiocarcinoma. J Am Coll Surg. 2011 Apr; 212(4):514-20; discussion 520-1. PMID: 21463781.
      View in: PubMed
    127. Chak E, Talal AH, Sherman KE, Schiff ER, Saab S. Hepatitis C virus infection in USA: an estimate of true prevalence. Liver Int. 2011 Sep; 31(8):1090-101. PMID: 21745274.
      View in: PubMed
    128. Han SH, Durazo FA, Saab S, Tong MJ. A proposed, evidence-based approach to the treatment of chronic Hepatitis B. J Clin Gastroenterol. 2011 Mar; 45(3):259-66. PMID: 20856136.
      View in: PubMed
    129. Saab S, Desai S, Tsaoi D, Durazo F, Han S, McClune A, Holt C, Farmer D, Goldstein L, Busuttil RW. Posttransplantation hepatitis B prophylaxis with combination oral nucleoside and nucleotide analog therapy. Am J Transplant. 2011 Mar; 11(3):511-7. PMID: 21299826.
      View in: PubMed
    130. El-Masry M, Puig CA, Gilbert CP, Saab S. Recurrence of non-viral liver disease after orthotopic liver transplantation. Liver Int. 2011 Mar; 31(3):291-302. PMID: 21281429.
      View in: PubMed
    131. Apisarnthanarak P, Raman SS, Ghobrial RM, Busuttil RW, Saab S, Lu DS. Efficacy of CT angiography for preoperative vascular mapping in adult to adult living related liver transplant donors. J Med Assoc Thai. 2011 Jan; 94(1):98-105. PMID: 21425734.
      View in: PubMed
    132. Sung H, Chang M, Saab S. Management of Hepatitis C Antiviral Therapy Adverse Effects. Curr Hepat Rep. 2011 Mar; 10(1):33-40. PMID: 21423320.
      View in: PubMed
    133. Saab S, McTigue M, Finn RS, Busuttil RW. Sorafenib as adjuvant therapy for high-risk hepatocellular carcinoma in liver transplant recipients: feasibility and efficacy. Exp Clin Transplant. 2010 Dec; 8(4):307-13. PMID: 21143097.
      View in: PubMed
    134. Chak E, Saab S. Risk factors and incidence of de novo malignancy in liver transplant recipients: a systematic review. Liver Int. 2010 Oct; 30(9):1247-58. PMID: 20602682.
      View in: PubMed
    135. Duffy JP, Kao K, Ko CY, Farmer DG, McDiarmid SV, Hong JC, Venick RS, Feist S, Goldstein L, Saab S, Hiatt JR, Busuttil RW. Long-term patient outcome and quality of life after liver transplantation: analysis of 20-year survivors. Ann Surg. 2010 Oct; 252(4):652-61. PMID: 20881772.
      View in: PubMed
    136. Foster T, Budoff MJ, Saab S, Ahmadi N, Gordon C, Guerci AD. Atorvastatin and antioxidants for the treatment of nonalcoholic fatty liver disease: the St Francis Heart Study randomized clinical trial. Am J Gastroenterol. 2011 Jan; 106(1):71-7. PMID: 20842109.
      View in: PubMed
    137. Chak E, Saab S. Pegylated Interferon and Ribavirin Dosing Strategies to Enhance Sustained Virologic Response. Curr Hepat Rep. 2010 Aug; 9(3):147-154. PMID: 20676191.
      View in: PubMed
    138. Movahedi Z, Holt CD, Saab S. Liver transplant: a primer. Exp Clin Transplant. 2010 Jun; 8(2):83-90. PMID: 20565363.
      View in: PubMed
    139. Saab S, Hunt DR, Stone MA, McClune A, Tong MJ. Timing of hepatitis C antiviral therapy in patients with advanced liver disease: a decision analysis model. Liver Transpl. 2010 Jun; 16(6):748-59. PMID: 20517909.
      View in: PubMed
    140. Desai S, Hong JC, Saab S. Cardiovascular risk factors following orthotopic liver transplantation: predisposing factors, incidence and management. Liver Int. 2010 Aug; 30(7):948-57. PMID: 20500807.
      View in: PubMed
    141. Walker NM, Stuart KA, Ryan RJ, Desai S, Saab S, Nicol JA, Fletcher LM, Crawford DH. Serum ferritin concentration predicts mortality in patients awaiting liver transplantation. Hepatology. 2010 May; 51(5):1683-91. PMID: 20225256.
      View in: PubMed
    142. Tong MJ, Hsu L, Hsien C, Kao JH, Durazo FA, Saab S, Blatt LM. A comparison of hepatitis B viral markers of patients in different clinical stages of chronic infection. Hepatol Int. 2010 Apr 07; 4(2):516-22. PMID: 20827410; PMCID: PMC2896649.
    143. Saab S, Waterman B, Chi AC, Tong MJ. Comparison of different immunoprophylaxis regimens after liver transplantation with hepatitis B core antibody-positive donors: a systematic review. Liver Transpl. 2010 Mar; 16(3):300-7. PMID: 20209589.
      View in: PubMed
    144. Tabibian JH, Asham EH, Han S, Saab S, Tong MJ, Goldstein L, Busuttil RW, Durazo FA. Endoscopic treatment of postorthotopic liver transplantation anastomotic biliary strictures with maximal stent therapy (with video). Gastrointest Endosc. 2010 Mar; 71(3):505-12. PMID: 20189508.
      View in: PubMed
    145. Bownik H, Saab S. Health-related quality of life after liver transplantation for adult recipients. Liver Transpl. 2009 Nov; 15 Suppl 2:S42-9. PMID: 19876941.
      View in: PubMed
    146. Saab S, Yeganeh M, Nguyen K, Durazo F, Han S, Yersiz H, Farmer DG, Goldstein LI, Tong MJ, Busuttil RW. Recurrence of hepatocellular carcinoma and hepatitis B reinfection in hepatitis B surface antigen-positive patients after liver transplantation. Liver Transpl. 2009 Nov; 15(11):1525-34. PMID: 19877207.
      View in: PubMed
    147. Bownik H, Saab S. The effects of hepatitis C recurrence on health-related quality of life in liver transplant recipients. Liver Int. 2010 Jan; 30(1):19-30. PMID: 19845850.
      View in: PubMed
    148. Martyak LA, Yeganeh M, Saab S. Hepatitis C and lymphoproliferative disorders: from mixed cryoglobulinemia to non-Hodgkin's lymphoma. Clin Gastroenterol Hepatol. 2009 Aug; 7(8):900-5. PMID: 19362606.
      View in: PubMed
    149. Saab S, Ham MY, Stone MA, Holt C, Tong M. Decision analysis model for hepatitis B prophylaxis one year after liver transplantation. Liver Transpl. 2009 Apr; 15(4):413-20. PMID: 19326401.
      View in: PubMed
    150. Kanwal F, Gralnek IM, Hays RD, Zeringue A, Durazo F, Han SB, Saab S, Bolus R, Spiegel BM. Health-related quality of life predicts mortality in patients with advanced chronic liver disease. Clin Gastroenterol Hepatol. 2009 Jul; 7(7):793-9. PMID: 19306949.
      View in: PubMed
    151. Saab S, Hernandez JC, Chi AC, Tong MJ. Oral antibiotic prophylaxis reduces spontaneous bacterial peritonitis occurrence and improves short-term survival in cirrhosis: a meta-analysis. Am J Gastroenterol. 2009 Apr; 104(4):993-1001; quiz 1002. PMID: 19277033.
      View in: PubMed
    152. Tong MJ, Hsien C, Song JJ, Kao JH, Sun HE, Hsu L, Han SH, Durazo FA, Saab S, Blatt LM. Factors associated with progression to hepatocellular carcinoma and to death from liver complications in patients with HBsAg-positive cirrhosis. Dig Dis Sci. 2009 Jun; 54(6):1337-46. PMID: 19242792.
      View in: PubMed
    153. Tabibian JH, Asham EH, Goldstein L, Han SH, Saab S, Tong MJ, Busuttil RW, Durazo FA. Endoscopic treatment with multiple stents for post-liver-transplantation nonanastomotic biliary strictures. Gastrointest Endosc. 2009 Jun; 69(7):1236-43. PMID: 19249040.
      View in: PubMed
    154. Hunt DR, Saab S. Viral hepatitis in incarcerated adults: a medical and public health concern. Am J Gastroenterol. 2009 Apr; 104(4):1024-31. PMID: 19240708.
      View in: PubMed
    155. Nyamathi A, Liu Y, Marfisee M, Shoptaw S, Gregerson P, Saab S, Leake B, Tyler D, Gelberg L. Effects of a nurse-managed program on hepatitis A and B vaccine completion among homeless adults. Nurs Res. 2009 Jan-Feb; 58(1):13-22. PMID: 19092551; PMCID: PMC3076026.
    156. Surti B, Tan J, Saab S. Pregnancy and liver transplantation. Liver Int. 2008 Nov; 28(9):1200-6. PMID: 18822076.
      View in: PubMed
    157. Tan JA, Joseph TA, Saab S. Treating hepatitis C in the prison population is cost-saving. Hepatology. 2008 Nov; 48(5):1387-95. PMID: 18924228.
      View in: PubMed
    158. Landaverde C, Saab S. Deciding liver transplant candidacy: tools of the trade. Liver Int. 2008 Nov; 28(9):1186-9. PMID: 18822075.
      View in: PubMed
    159. Campsen J, Blei AT, Emond JC, Everhart JE, Freise CE, Lok AS, Saab S, Wisniewski KA, Trotter JF. Outcomes of living donor liver transplantation for acute liver failure: the adult-to-adult living donor liver transplantation cohort study. Liver Transpl. 2008 Sep; 14(9):1273-80. PMID: 18756453; PMCID: PMC3732478.
    160. Tan J, Surti B, Saab S. Pregnancy and cirrhosis. Liver Transpl. 2008 Aug; 14(8):1081-91. PMID: 18668664.
      View in: PubMed
    161. Shim M, Saab S. Severe hepatotoxicity due to Hydroxycut: a case report. Dig Dis Sci. 2009 Feb; 54(2):406-8. PMID: 18661239.
      View in: PubMed
    162. Saab S, Ibrahim AB, Surti B, Durazo F, Han S, Yersiz H, Farmer DG, Ghobrial RM, Goldstein LI, Tong MJ, Busuttil RW. Pretransplant variables associated with quality of life in liver transplant recipients. Liver Int. 2008 Sep; 28(8):1087-94. PMID: 18662279.
      View in: PubMed
    163. Dong MH, Saab S. Complications of cirrhosis. Dis Mon. 2008 Jul; 54(7):445-56. PMID: 18570914.
      View in: PubMed
    164. Durazo FA, Blatt LM, Corey WG, Lin JH, Han S, Saab S, Busuttil RW, Tong MJ. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma. J Gastroenterol Hepatol. 2008 Oct; 23(10):1541-8. PMID: 18422961.
      View in: PubMed
    165. Yuan Y, Iloeje UH, Hay J, Saab S. Evaluation of the cost-effectiveness of entecavir versus lamivudine in hepatitis BeAg-positive chronic hepatitis B patients. J Manag Care Pharm. 2008 Jan-Feb; 14(1):21-33. PMID: 18240879.
      View in: PubMed
    166. Martyak LA, Taqavi E, Saab S. Lamivudine prophylaxis is effective in reducing hepatitis B reactivation and reactivation-related mortality in chemotherapy patients: a meta-analysis. Liver Int. 2008 Jan; 28(1):28-38. PMID: 17976155.
      View in: PubMed
    167. Trotter JF, Wisniewski KA, Terrault NA, Everhart JE, Kinkhabwala M, Weinrieb RM, Fair JH, Fisher RA, Koffron AJ, Saab S, Merion RM. Outcomes of donor evaluation in adult-to-adult living donor liver transplantation. Hepatology. 2007 Nov; 46(5):1476-84. PMID: 17668879; PMCID: PMC3732162.
    168. Saab S, Dong MH, Joseph TA, Tong MJ. Hepatitis B prophylaxis in patients undergoing chemotherapy for lymphoma: a decision analysis model. Hepatology. 2007 Oct; 46(4):1049-56. PMID: 17680650.
      View in: PubMed
    169. Saab S, Wiese C, Ibrahim AB, Peralta L, Durazo F, Han S, Yersiz H, Farmer DG, Ghobrial RM, Goldstein LI, Tong MJ, Busuttil RW. Employment and quality of life in liver transplant recipients. Liver Transpl. 2007 Sep; 13(9):1330-8. PMID: 17763388.
      View in: PubMed
    170. Saab S, Oh MK, Ibrahim AB, Durazo F, Han S, Yersiz H, Farmer DG, Ghobrial RM, Goldstein LI, Tong MJ, Busuttil RW. Anemia in liver transplant recipients undergoing antiviral treatment for recurrent hepatitis C. Liver Transpl. 2007 Jul; 13(7):1032-8. PMID: 17600345.
      View in: PubMed
    171. Trotter JF, Hill-Callahan MM, Gillespie BW, Nielsen CA, Saab S, Shrestha R, Talamantes MM, Weinrieb RM. Severe psychiatric problems in right hepatic lobe donors for living donor liver transplantation. Transplantation. 2007 Jun 15; 83(11):1506-8. PMID: 17565325; PMCID: PMC3762598.
    172. Otsuka Y, Duffy JP, Saab S, Farmer DG, Ghobrial RM, Hiatt JR, Busuttil RW. Postresection hepatic failure: successful treatment with liver transplantation. Liver Transpl. 2007 May; 13(5):672-9. PMID: 17219396.
      View in: PubMed
    173. Terrault NA, Shiffman ML, Lok AS, Saab S, Tong L, Brown RS, Everson GT, Reddy KR, Fair JH, Kulik LM, Pruett TL, Seeff LB. Outcomes in hepatitis C virus-infected recipients of living donor vs. deceased donor liver transplantation. Liver Transpl. 2007 Jan; 13(1):122-9. PMID: 17192908; PMCID: PMC3155862.
    174. Saab S, Nguyen S, Collins J, Kunder G, Busuttil RW. Lymphedema tarda after liver transplantation: a case report and review of the literature. Exp Clin Transplant. 2006 Dec; 4(2):567-70. PMID: 17238860.
      View in: PubMed
    175. Saab S, Nieto JM, Lewis SK, Runyon BA. TIPS versus paracentesis for cirrhotic patients with refractory ascites. Cochrane Database Syst Rev. 2006 Oct 18; (4):CD004889. PMID: 17054221.
      View in: PubMed
    176. Cameron AM, Ghobrial RM, Hiatt JR, Carmody IC, Gordon SA, Farmer DG, Yersiz H, Zimmerman MA, Durazo F, Han SH, Saab S, Gornbein J, Busuttil RW. Effect of nonviral factors on hepatitis C recurrence after liver transplantation. Ann Surg. 2006 Oct; 244(4):563-71. PMID: 16998365; PMCID: PMC1856558.
    177. Saab S, Landaverde C, Ibrahim AB, Durazo F, Han S, Yersiz H, Farmer DG, Ghobrial RM, Goldstein LI, Tong MJ, Busuttil RW. The MELD score in advanced liver disease: association with clinical portal hypertension and mortality. Exp Clin Transplant. 2006 Jun; 4(1):395-9. PMID: 16827633.
      View in: PubMed
    178. Biggins SW, Kim WR, Terrault NA, Saab S, Balan V, Schiano T, Benson J, Therneau T, Kremers W, Wiesner R, Kamath P, Klintmalm G. Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology. 2006 May; 130(6):1652-60. PMID: 16697729.
      View in: PubMed
    179. Saab S, Nguyen S, Ibrahim A, Vierling JM, Tong MJ. Management of patients with cirrhosis in Southern California: results of a practitioner survey. J Clin Gastroenterol. 2006 Feb; 40(2):156-61. PMID: 16394878.
      View in: PubMed
    180. Saab S, Niho H, Comulada S, Hiatt J, Durazo F, Han S, Farmer DG, Holt C, Yersiz H, Goldstein LI, Ghobrial RM, Busuttil RW. Mortality predictors in liver transplant recipients with recurrent hepatitis C cirrhosis. Liver Int. 2005 Oct; 25(5):940-5. PMID: 16162150.
      View in: PubMed
    181. Kim AI, Saab S. Treatment of hepatitis C. Am J Med. 2005 Aug; 118(8):808-15. PMID: 16084169.
      View in: PubMed
    182. Jacobs RJ, Meyerhoff AS, Saab S. Immunization needs of chronic liver disease patients seen in primary care versus specialist settings. Dig Dis Sci. 2005 Aug; 50(8):1525-31. PMID: 16110847.
      View in: PubMed
    183. Busuttil RW, Farmer DG, Yersiz H, Hiatt JR, McDiarmid SV, Goldstein LI, Saab S, Han S, Durazo F, Weaver M, Cao C, Chen T, Lipshutz GS, Holt C, Gordon S, Gornbein J, Amersi F, Ghobrial RM. Analysis of long-term outcomes of 3200 liver transplantations over two decades: a single-center experience. Ann Surg. 2005 Jun; 241(6):905-16; discussion 916-8. PMID: 15912040; PMCID: PMC1357170.
    184. Lu DS, Yu NC, Raman SS, Lassman C, Tong MJ, Britten C, Durazo F, Saab S, Han S, Finn R, Hiatt JR, Busuttil RW. Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation. Hepatology. 2005 May; 41(5):1130-7. PMID: 15841454.
      View in: PubMed
    185. Saab S, Ibrahim AB, Shpaner A, Younossi ZM, Lee C, Durazo F, Han S, Esrason K, Wu V, Hiatt J, Farmer DG, Ghobrial RM, Holt C, Yersiz H, Goldstein LI, Tong MJ, Busuttil RW. MELD fails to measure quality of life in liver transplant candidates. Liver Transpl. 2005 Feb; 11(2):218-23. PMID: 15666392.
      View in: PubMed
    186. Saab S, Cho D, Lassman RC, Gajjar NA, Ghobrial M, Busuttil RW. Recurrent non-alcoholic steatohepatitis in a living related liver transplant recipient. J Hepatol. 2005 Jan; 42(1):148-9. PMID: 15629523.
      View in: PubMed
    187. Saab S, Lee C, Shpaner A, Ibrahim AB. Seroepidemiology of hepatitis A in patients with chronic liver disease. J Viral Hepat. 2005 Jan; 12(1):101-5. PMID: 15655056.
      View in: PubMed
    188. Shimoda M, Ghobrial RM, Carmody IC, Anselmo DM, Farmer DG, Yersiz H, Chen P, Dawson S, Durazo F, Han S, Goldstein LI, Saab S, Hiatt J, Busuttil RW. Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C. Liver Transpl. 2004 Dec; 10(12):1478-86. PMID: 15558585.
      View in: PubMed
    189. Saab S, Cho D, Quon DV, Ibrahim AB, Dong P, Marder V, Logan L. Same day outpatient transjugular liver biopsies in haemophilia. Haemophilia. 2004 Nov; 10(6):727-31. PMID: 15569168.
      View in: PubMed
    190. Saab S, Kalmaz D, Gajjar NA, Hiatt J, Durazo F, Han S, Farmer DG, Ghobrial RM, Yersiz H, Goldstein LI, Lassman CR, Busuttil RW. Outcomes of acute rejection after interferon therapy in liver transplant recipients. Liver Transpl. 2004 Jul; 10(7):859-67. PMID: 15237369.
      View in: PubMed
    191. Durazo FA, Lassman C, Han SH, Saab S, Lee NP, Kawano M, Saggi B, Gordon S, Farmer DG, Yersiz H, Goldstein RL, Ghobrial M, Busuttil RW. Fulminant liver failure due to usnic acid for weight loss. Am J Gastroenterol. 2004 May; 99(5):950-2. PMID: 15128366.
      View in: PubMed
    192. Limanond P, Raman SS, Ghobrial RM, Busuttil RW, Saab S, Lu DS. Preoperative imaging in adult-to-adult living related liver transplant donors: what surgeons want to know. J Comput Assist Tomogr. 2004 Mar-Apr; 28(2):149-57. PMID: 15091116.
      View in: PubMed
    193. Wang VS, Saab S. Liver transplantation in the era of model for end-stage liver disease. Liver Int. 2004 Feb; 24(1):1-8. PMID: 15101994.
      View in: PubMed
    194. Limanond P, Raman SS, Lassman C, Sayre J, Ghobrial RM, Busuttil RW, Saab S, Lu DS. Macrovesicular hepatic steatosis in living related liver donors: correlation between CT and histologic findings. Radiology. 2004 Jan; 230(1):276-80. PMID: 14695401.
      View in: PubMed
    195. Yao FY, Saab S, Bass NM, Hirose R, Ly D, Terrault N, Lazar AA, Bacchetti P, Ascher NL, Roberts JP. Prediction of survival after liver retransplantation for late graft failure based on preoperative prognostic scores. Hepatology. 2004 Jan; 39(1):230-8. PMID: 14752842.
      View in: PubMed
    196. Karsan HA, Rojter SE, Saab S. Primary prevention of cirrhosis. Public health strategies that can make a difference. Postgrad Med. 2004 Jan; 115(1):25-30. PMID: 14755873.
      View in: PubMed
    197. Saab S, Nieto JM, Ly D, Runyon BA. TIPS versus paracentesis for cirrhotic patients with refractory ascites. Cochrane Database Syst Rev. 2004; (3):CD004889. PMID: 15266548.
      View in: PubMed
    198. Chang AJ, Dixit V, Saab S. Fulminant Hepatic Failure. Curr Treat Options Gastroenterol. 2003 Dec; 6(6):473-479. PMID: 14585236.
      View in: PubMed
    199. Kanwal F, Chen D, Ting L, Gornbein J, Saab S, Durazo F, Yersiz H, Farmer D, Ghobrial RM, Busuttil RW, Han SH. A model to predict the development of mental status changes of unclear cause after liver transplantation. Liver Transpl. 2003 Dec; 9(12):1312-9. PMID: 14625832.
      View in: PubMed
    200. Jacobs RJ, Saab S, Meyerhoff AS, Koff RS. An economic assessment of pre-vaccination screening for hepatitis A and B. Public Health Rep. 2003 Nov-Dec; 118(6):550-8. PMID: 14563912; PMCID: PMC1497596.
    201. Jacobs RJ, Greenberg DP, Koff RS, Saab S, Meyerhoff AS. Regional variation in the cost effectiveness of childhood hepatitis A immunization. Pediatr Infect Dis J. 2003 Oct; 22(10):904-14. PMID: 14551492.
      View in: PubMed
    202. Saab S, Chang AJ, Comulada S, Geevarghese SK, Anselmo RD, Durazo F, Han S, Farmer DG, Yersiz H, Goldstein LI, Ghobrial RM, Busuttil RW. Outcomes of hepatitis C- and hepatitis B core antibody-positive grafts in orthotopic liver transplantation. Liver Transpl. 2003 Oct; 9(10):1053-61. PMID: 14526400.
      View in: PubMed
    203. Saab S, Ghobrial RM, Ibrahim AB, Kunder G, Durazo F, Han S, Farmer DG, Yersiz H, Goldstein LI, Busuttil RW. Hepatitis C positive grafts may be used in orthotopic liver transplantation: a matched analysis. Am J Transplant. 2003 Sep; 3(9):1167-72. PMID: 12919097.
      View in: PubMed
    204. Saab S, Wang V. Recurrent hepatitis C following liver transplant: diagnosis, natural history, and therapeutic options. J Clin Gastroenterol. 2003 Aug; 37(2):155-63. PMID: 12869888.
      View in: PubMed
    205. Saab S, Busuttil RW. Practical management of liver transplant recipients for hepatitis C. Minerva Chir. 2003 Aug; 58(4):479-89. PMID: 14603160.
      View in: PubMed
    206. Saab S, Ly D, Nieto J, Kanwal F, Lu D, Raman S, Amado R, Nuesse B, Durazo F, Han S, Farmer DG, Ghobrial RM, Yersiz H, Chen P, Schwegel K, Goldstein LI, Tong M, Busuttil RW. Hepatocellular carcinoma screening in patients waiting for liver transplantation: a decision analytic model. Liver Transpl. 2003 Jul; 9(7):672-81. PMID: 12827551.
      View in: PubMed
    207. Jacobs RJ, Saab S, Meyerhoff AS. The cost effectiveness of hepatitis immunization for US college students. J Am Coll Health. 2003 May; 51(6):227-36. PMID: 14510025.
      View in: PubMed
    208. Farmer DG, Anselmo DM, Ghobrial RM, Yersiz H, McDiarmid SV, Cao C, Weaver M, Figueroa J, Khan K, Vargas J, Saab S, Han S, Durazo F, Goldstein L, Holt C, Busuttil RW. Liver transplantation for fulminant hepatic failure: experience with more than 200 patients over a 17-year period. Ann Surg. 2003 May; 237(5):666-75; discussion 675-6. PMID: 12724633; PMCID: PMC1514517.
    209. Saab S, Wang V, Ibrahim AB, Durazo F, Han S, Farmer DG, Yersiz H, Morrisey M, Goldstein LI, Ghobrial RM, Busuttil RW. MELD score predicts 1-year patient survival post-orthotopic liver transplantation. Liver Transpl. 2003 May; 9(5):473-6. PMID: 12740789.
      View in: PubMed
    210. Tang SJ, Geevarghese S, Saab S, Martinez D, Van Herle A, Wallace WD, Cortina GR, Dry S, Busuttil RW. A parathyroid hormone-related protein-secreting metastatic epithelioid leiomyosarcoma. A case report and review of the literature. Arch Pathol Lab Med. 2003 Apr; 127(4):e181-5. PMID: 12683897.
      View in: PubMed
    211. Saab S, DeRosa V, Nieto J, Durazo F, Han S, Roth B. Costs and clinical outcomes of primary prophylaxis of variceal bleeding in patients with hepatic cirrhosis: a decision analytic model. Am J Gastroenterol. 2003 Apr; 98(4):763-70. PMID: 12738453.
      View in: PubMed
    212. Saab S, Hu R, Ibrahim AB, Goldstein LI, Kunder G, Durazo F, Han S, Yersiz H, Ghobrial RM, Farmer DG, Busuttil RW, Lassman C. Discordance between ALT values and fibrosis in liver transplant recipients treated with ribavirin for recurrent hepatitis C. Am J Transplant. 2003 Mar; 3(3):328-33. PMID: 12614290.
      View in: PubMed
    213. Wang V, Saab S. Ammonia levels and the severity of hepatic encephalopathy. Am J Med. 2003 Feb 15; 114(3):237-8. PMID: 12637141.
      View in: PubMed
    214. Han SH, Martin P, Edelstein M, Hu R, Kunder G, Holt C, Saab S, Durazo F, Goldstein L, Farmer D, Ghobrial RM, Busuttil RW. Conversion from intravenous to intramuscular hepatitis B immune globulin in combination with lamivudine is safe and cost-effective in patients receiving long-term prophylaxis to prevent hepatitis B recurrence after liver transplantation. Liver Transpl. 2003 Feb; 9(2):182-7. PMID: 12548512.
      View in: PubMed
    215. Saab S, Tam S, Tran Bi, Melton A, Tangkijvanich P, Wong H, Yee H. Myosin mediates contractile force generation by hepatic stellate cells in response to endothelin-1. J Biomed Sci. 2002 Nov-Dec; 9(6 Pt 2):607-12. PMID: 12432226.
      View in: PubMed
    216. Ghobrial RM, Saab S, Lassman C, Lu DS, Raman S, Limanond P, Kunder G, Marks K, Amersi F, Anselmo D, Chen P, Farmer D, Han S, Durazo F, Goldstein LI, Busuttil RW. Donor and recipient outcomes in right lobe adult living donor liver transplantation. Liver Transpl. 2002 Oct; 8(10):901-9. PMID: 12360431.
      View in: PubMed
    217. Ghobrial RM, Gornbein J, Steadman R, Danino N, Markmann JF, Holt C, Anselmo D, Amersi F, Chen P, Farmer DG, Han S, Derazo F, Saab S, Goldstein LI, McDiarmid SV, Busuttil RW. Pretransplant model to predict posttransplant survival in liver transplant patients. Ann Surg. 2002 Sep; 236(3):315-22; discussion 322-3. PMID: 12192318; PMCID: PMC1422585.
    218. Saab S, Weston SR, Ly D, Brezina M, Yee HF, Han SH, Gitnick G. Comparison of the cost and effectiveness of two strategies for maintaining hepatitis B immunity in hemodialysis patients. Vaccine. 2002 Aug 19; 20(25-26):3230-5. PMID: 12163275.
      View in: PubMed
    219. Nyamathi A, Robbins WA, Fahey JL, Wiley D, Pekler VA, Longshore D, Robins TA, Singh J, Saab S. Presence and predictors of hepatitis C virus RNA in the semen of homeless men. Biol Res Nurs. 2002 Jul; 4(1):22-30. PMID: 12363279.
      View in: PubMed
    220. Anselmo DM, Ghobrial RM, Jung LC, Weaver M, Cao C, Saab S, Kunder G, Chen PW, Farmer DG, Yersiz H, Baquerizo A, Geevarghese S, Han SH, Goldstein L, Holt CD, Gornbein JA, Busuttil RW. New era of liver transplantation for hepatitis B: a 17-year single-center experience. Ann Surg. 2002 May; 235(5):611-9; discussion 619-20. PMID: 11981206; PMCID: PMC1422486.
    221. Saab S, Ly D, Han SB, Lin RK, Rojter SE, Ghobrial RM, Busuttil RW. Is it cost-effective to treat recurrent hepatitis C infection in orthotopic liver transplantation patients? Liver Transpl. 2002 May; 8(5):449-57. PMID: 12004345.
      View in: PubMed
    222. Ly D, Yee HF, Brezina M, Martin P, Gitnick G, Saab S. Hepatitis B surface antigenemia in chronic hemodialysis patients: effect of hepatitis B immunization. Am J Gastroenterol. 2002 Jan; 97(1):138-41. PMID: 11808938.
      View in: PubMed
    223. Saab S, Kim M, Wright TL, Han SH, Martin P, Busuttil RW. Successful orthotopic liver transplantation for lamivudine-associated YMDD mutant hepatitis B virus. Gastroenterology. 2000 Nov; 119(5):1382-4. PMID: 11054397.
      View in: PubMed